BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients

Abstract

We determined the prevalence and clinicopathological associations of BRAF V600E and TERT promoter mutations in Chinese PTC patients. TERT promoter mutations but not the BRAF V600E mutation were associated with more advanced TNM stage upon diagnosis.